Bone marrow mesenchymal stem cell transplantation for treatment of emphysemic rats
- PMID: 24955169
- PMCID: PMC4057848
Bone marrow mesenchymal stem cell transplantation for treatment of emphysemic rats
Abstract
Objective: To study the efficacy of bone marrow mesenchymal stem cell (MSC) transplantation to treat pulmonary emphysema in rats.
Methods: Sixty rats were randomly divided into control, model and transplantation groups. Each group contained 20 rats. Rat models of emphysema were established via intratracheal instillation of lipopolysaccharide and exposure of model and transplantation groups to smoke. Then, cultured bone marrow MSCs were injected into rats in the transplantation group via the tail vein. Pathological changes of the lung in rats were observed.
Results: Emphysemic pathological changes were found in model and transplantation groups, but changes were significantly attenuated after transplantation, compared with that of the model group. The mean alveoli number (MAN) and pulmonary alveolar area (PAA) showed statistically significant differences among the three groups (P < 0.001). The MAN in the transplantation group was higher than that in the model group, but still lower than that in the control group. The PAA in the transplantation group was lower than that in the model group, but higher than that in the control group (P < 0.05). After transplantation, Brdu-positive cells were observed and CK was expressed in a small number of Brdu-positive cells. Brdu- and CK-positive cells were not found in control and model groups.
Conclusion: Transplantation of bone marrow MSCs can significantly attenuate lung inflammation and pathological changes in emphysemic rats, which may be associated with MSC differentiation into alveolar epithelial cells in recipient lung tissues.
Keywords: Bone marrow; emphysema; mesenchymal stem cells; transplantation.
Figures



Similar articles
-
[Effects and possible mechanisms of mesenchymal stem cell transplantation on emphysema in rats].Zhonghua Yi Xue Za Zhi. 2015 Jun 9;95(22):1731-5. Zhonghua Yi Xue Za Zhi. 2015. PMID: 26704156 Chinese.
-
[The effect of marrow mesenchymal stem cell transplantation on pulmonary fibrosis in rats].Zhonghua Jie He He Hu Xi Za Zhi. 2012 Sep;35(9):659-64. Zhonghua Jie He He Hu Xi Za Zhi. 2012. PMID: 23158067 Chinese.
-
[Effects of bone marrow mesenchymal stem cells transplantation on the apoptosis of alveolar wall cells in papain and Co60-induced pulmonary emphysema rats].Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008 May;24(2):210-4. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008. PMID: 21141529 Chinese.
-
Mesenchymal stem cells transplantation protects against rat pulmonary emphysema.Front Biosci. 2008 May 1;13:3415-22. doi: 10.2741/2936. Front Biosci. 2008. PMID: 18508443
-
[Effect of intra-bone marrow infusion of allogeneic mesenchymal stem cells on reconstruction of marrow mesenchymal stem cells in rat HSCT models].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1334-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 19099639 Chinese.
Cited by
-
Stem cell therapies for chronic obstructive pulmonary disease: mesenchymal stem cells as a promising treatment option.Stem Cell Res Ther. 2024 Sep 19;15(1):312. doi: 10.1186/s13287-024-03940-9. Stem Cell Res Ther. 2024. PMID: 39300523 Free PMC article. Review.
-
Effects of bone marrow‑derived mesenchymal stem cell transplantation on chronic obstructive pulmonary disease/obstructive sleep apnea overlap syndrome in rats.Mol Med Rep. 2019 Nov;20(5):4665-4673. doi: 10.3892/mmr.2019.10714. Epub 2019 Sep 30. Mol Med Rep. 2019. PMID: 31702032 Free PMC article.
-
Mesenchymal stromal cell therapy in COPD: from bench to bedside.Int J Chron Obstruct Pulmon Dis. 2017 Oct 16;12:3017-3027. doi: 10.2147/COPD.S146671. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29081655 Free PMC article. Review.
-
Conventional and Nanotechnology Based Approaches to Combat Chronic Obstructive Pulmonary Disease: Implications for Chronic Airway Diseases.Int J Nanomedicine. 2020 May 28;15:3803-3826. doi: 10.2147/IJN.S242516. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32547029 Free PMC article. Review.
-
Can Youthful Mesenchymal Stem Cells from Wharton's Jelly Bring a Breath of Fresh Air for COPD?Int J Mol Sci. 2017 Nov 18;18(11):2449. doi: 10.3390/ijms18112449. Int J Mol Sci. 2017. PMID: 29156550 Free PMC article. Review.
References
-
- Tochino Y, Asai K, Hirata K. Bronchial asthma: progress in diagnosis and treatments. Topics: I. Basic knowledge; 4. Differentiation and coexistence with COPD. Nihon Naika Gakkai Zasshi. 2013;102:1352–8. - PubMed
-
- Zhou JB, Zhang J, Bai CX. Progress in the mechanisms of chronic obstructive pulmonary disease co-morbid lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2012;35:288–90. - PubMed
-
- Kawamoto K, Konno M, Nagano H, Nishikawa S, Tomimaru Y, Akita H, Hama N, Wada H, Kobayashi S, Eguchi H, Tanemura M, Ito T, Doki Y, Mori M, Ishii H. CD90-(Thy-1-) High Selection Enhances Reprogramming Capacity of Murine Adipose-Derived Mesenchymal Stem Cells. Dis Markers. 2013;35:573–9. - PMC - PubMed
-
- Xu C. Transplantation of neural stem cells and bone marrow mesenchymal stem cells in treatment of spinal cord injury. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012;26:186–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials